[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance: Sunscreen Innovation Act: Withdrawal of a 586A Request or Pending Request.[ Price : $8.95]
Federal Register Notice: FDA releases a draft guidance: Sunscreen Innovation Act: Section 586C(c) Advisory Committee Process.[ Price : $8.95]
Due to ongoing implementation challenges with a new Clozapine Risk Evaluation and Mitigation Strategies program, FDA extends its 1...[ Price : $8.95]
A JAMA Viewpoint article authored by FDA commissioner-nominee Robert Califf describes ongoing efforts at the agency on patient pre...[ Price : $8.95]
Janssen Research and Development files an NDA for Invokamet XR, a once-daily therapy combining fixed doses of its Invokana canagli...[ Price : $8.95]
Event Medical begins a Class 1 recall of its Inspiration Ventilator System, i Series and LS 12.1 LCD models because a component on...[ Price : $8.95]
FDA approves a Takeda Pharmaceuticals NDA for Ninlaro (ixazomib) for combination use with two other therapies to treat people with...[ Price : $8.95]
FDA releases four draft guidances as required by the Sunscreen Innovation Act that provides the agencys current thinking on the sc...